News

The Norwegian government has come up with five key principles it believes the next Framework programme should adhere to: excellence, impact, openness, simplicity and European added value

EU and UK negotiators are not seen as far apart on research, but with Article 50 now triggered, getting a deal on R&D is likely to be some way down the list of priorities

A proposed amendment “is a direct and fundamental threat” to the Budapest-based Central European University, says president and rector Michael Ignatieff

EU leaders stressed the importance of technology and innovation in a birthday declaration signed in Rome. Now there is optimistic talk of €100B for the next Framework programme, but Brexit could be a dampener

It is one thing to be bested by the mighty US clusters of Silicon Valley or Cambridge, but seeing a major technology investment go to the rural state of Mississippi is hard to swallow

Amid the 10th birthday celebrations, ERC president Jean-Pierre Bourguignon set down a marker for the future, suggesting the annual budget should rise to €4 billion over the next ten years.

The competition among cities vying to replace London as home of the drug regulator is hotting up. A decision on the new location could be announced before June

The number of EU approved drugs for treating rare diseases is increasing but high prices and restrictive reimbursement policies are preventing patients from getting access.

Although patient-reported outcomes (PROMs) are being promoted as a way to optimise treatment, it is not clear that patients and doctors agree on how PROMs are interpreted.